Leimkuhler William F. 4

What Happened
William F. Leimkuhler, a director of Argan, Inc. (AGX), sold a total of 5,800 shares of the company's common stock in open-market transactions on April 28, 2026. The sales consisted of: 5,000 shares at an average price of $617.41 (approximately $3,087,050), 400 shares at $621.14 ($248,456) and 400 shares at $618.61 ($247,444). Total proceeds reported are about $3,582,950. These were sales (S) — not purchases or option exercises — and sales are often routine transactions rather than a clear signal about company prospects.

Key Details

• Transaction date: April 28, 2026; Form 4 filed April 29, 2026 (appears timely).
• Prices and amounts: 5,000 @ $617.41; 400 @ $621.14; 400 @ $618.61. Total ≈ $3,582,950.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 notes the 5,000-share sale was an open-market sale at an average price of $617.41. F2 and F3 indicate the two 400-share lots were sold by the Emily K. Leimkuhler Trust and the Elizabeth K. Leimkuhler Trust, respectively — trusts for which the reporting person serves as trustee.
• Transaction code: S = Sale (open market). No 10b5-1 plan, tax-withholding, or other special conditions were disclosed in the provided footnotes.

Context
Sales by directors can be for many personal or estate-planning reasons and do not necessarily indicate a change in view on the company. Here, part of the activity was executed by trusts of which Leimkuhler is trustee; the filing does not state any motivation. For retail investors, purchases tend to carry more weight as signals; this Form 4 documents routine insider selling activity.